Oxford-AZ vaccine ‘effective against dominant UK variant’
The developers said it worked equally well against the new dominant variant and the original virus. …
“Coronaviruses are less prone to mutation than influenza viruses, but we have always expected that as the pandemic continues, new variants will begin to become dominant among the viruses that are circulating and that eventually a new version of the vaccine, with an updated spike protein, would be required to maintain vaccine efficacy at the highest level possible.”